Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today announced that Fabien de Ladonchamps, Chief Administrative Officer, is stepping down from the Company’s Executive Committee, effective immediately. Fabien de Ladonchamps will remain a member of senior management.
Read more at globenewswire.com